Eurogentec is an international biotechnology supplier, based in Belgium, that specializes in genomics and proteomics kits and reagents as well as cGMP biologics. The company was founded in 1985 as a spin-off from the University of Liège. Eurogentec's contract manufacturing organization facilities are licensed by the Belgian Ministry of Health to produce clinical trial and commercial biopharmaceutical material and also licensed by the US FDA to manufacture a commercial recombinant protein product for the US market. Eurogentec operates two manufacturing facilities in Belgium that provide custom biologics and oligonucleotide-based components for diagnostic and therapeutic applications. Wikipedia.
News Article | May 15, 2017
— Increasing health care awareness, growing investments on research & development, and introduction of innovative products are the factors propelling the market growth. In addition, growing proteomics research is bolstering the market growth. However, limited number of skilled professionals, high costs of products is the restrains hindering the market growth. Among all product segments, reagents is anticipated to dominate the market over the forecast period. This dominance is accounted for growing demand for peptide binding agents and increasing research and development activities. By application, immunological techniques segment represents largest segment with a higher market share. North America is anticipated to hold the largest share in global protein labeling market due to increasing demand from U.S. and Asia Pacific is likely to grow at a moderate rate during the forecast period. Some of the key players in global protein labeling market include Agilent Technologies Inc., Bio-Rad Laboratories, Eurogentec S.A, F. Hoffman-La Roche AG, General Electric Company, Kaneka Corporation, Kirkegaard & Perry Laboratories (KPL), Li-Cor, Inc., Merck KGaA (Germany), New England Biolabs, Perkinelmer, Inc., Promega Corporation, Qiagen N.V., Seracare Life Sciences, Inc., and Thermo Fisher Scientific, Inc. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Stratistics MRC We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. For more information, please visit http://www.strategymrc.com/
News Article | May 16, 2017
Dublin, May 16, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Lyophilization Services for Biopharmaceuticals, 2017-2027" report to their offering. The Lyophilization Services for Biopharmaceuticals, 2017-2027' report provides an extensive study on the current market landscape of lyophilization services for biopharmaceuticals. The study presents an in-depth analysis of a diverse set of companies that provide such services across different regions worldwide. In fact, we identified close to 90 companies that are actively involved in providing lyophilization services for biopharmaceuticals. The study features a detailed analysis of the existing size and potential future growth opportunities (2017-2027) in the lyophilization services market for biopharmaceuticals. We have provided insights on the likely regional evolution of the market covering North America, Europe (UK, France, Italy, Spain, Germany and rest of Europe), Asia Pacific (Japan, China, India and South Korea) and rest of the world. In addition, we have provided the likely evolution and a market attractiveness analysis on the basis of the type of containment system (bulk containers, vials, syringes, ampoules and cartridges). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have presented three different forecast scenarios, depicting conservative, base and optimistic tracks of the market's evolution. The research, analysis and insights presented in this report are backed by a deep understanding of key insights gathered from both secondary and primary research. Actual figures have been sourced and analyzed from publicly available data. For the purpose of the study, we invited over 80 stakeholders to participate in a survey to solicit their opinions on upcoming opportunities, challenges and likely future trends. The opinions and insights presented in this study were also influenced by discussions conducted with experts in this field. These included contributions from Steven Nail (Principal Scientist, Baxter BioPharma Solutions), Adam Viverette (Lyophilization Manager, Patheon), Patrick DePalma (Director, CMO Business Development, BioDefense Division, Emergent BioSolutions) and John Shaw (Head of Business Development and Marketing, Vibalogics). Key Topics Covered: 1. PREFACE 1.1. Scope of the Report 1.2. Research Methodology 1.3. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION TO LYOPHILIZATION 3.1. Chapter Overview 3.2. Lyophilization: Historical Background 3.3. Lyophilization: Underlying Principle 3.4. Lyophilization: Equipment 3.5. Lyophilization: Advantages and Disadvantages 3.6. Lyophilization: Applications 4. LYOPHILIZATION OF BIOPHARMACEUTICALS 4.1. Chapter Overview 4.2. Need for Lyophilization of Biopharmaceuticals 4.3. Lyophilization Process for Biopharmaceuticals 4.4. Lyophilization Cycle Development and Optimization 4.5. Containment Systems Used for the Lyophilization of Biopharmaceuticals 5. COMPETITIVE LANDSCAPE 5.1. Chapter Overview 5.2. Lyophilization Service Providers for Biopharmaceuticals: Overall Landscape 5.3. Lyophilization Service Providers for Biopharmaceuticals: Analysis by Type of Biopharmaceuticals Lyophilized 5.4. Lyophilization Service Provides for Biopharmaceuticals: Analysis by Scale of Operation 5.5. Lyophilization Service Providers for Biopharmaceuticals: Analysis by Containment Systems 6. LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS: NORTH AMERICA 6.1. Chapter Overview 6.2. Anteco Pharma 6.3. Axcellerate Pharma 6.4. Berkshire Sterile Manufacturing 6.5. Emergent BioSolutions 6.6. LSNE Contract Manufacturing 6.7. Lyophilization Technology 6.8. Quality BioResources 6.9. North America: Lyophilization Services Market for Biopharmaceuticals, 2017-2027 (USD Million) 7. LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS: EUROPE 7.1. Chapter Overview 7.2. Amatsigroup 7.3. Biopharma Technology 7.4. Boehringer Ingelheim BioXcellence 7.5. LYOCONTRACT 7.6. Lyofal 7.7. Vetter Pharma 7.8. Europe: Lyophilization Services Market for Biopharmaceuticals, 2017-2027 (USD Million) 8. LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS: ASIA PACIFIC 8.1. Chapter Overview 8.2. BioZed Engineering 8.3. Bovogen Biologics 8.4. CinnaGen 8.5. Mycenax Biotech 8.6. Piramal Pharma Solutions 8.7. Samsung Biologics 8.8. Siam Bioscience 8.9. WuXi AppTec 8.10. Asia Pacific: Lyophilization Services Market for Biopharmaceuticals, 2017-2027 (USD Million) 8.10.1. Asia Pacific Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Containment System (USD Million) 9. MARKET SIZING AND FORECAST 9.1. Chapter Overview 9.2. Forecast Methodology 9.3. Lyophilization Services Market for Biopharmaceuticals, 2017-2027 (USD Million) 9.4. Lyophilization Services Market for Biopharmaceuticals, 2017-2027: Distribution by Region (USD Million) 9.5. Lyophilization Services Market for Biopharmaceuticals, 2017-2027: Distribution by Type of Containment System (USD Million) 10. BENCHMARK ANALYSIS 10.1. Chapter Overview 10.2. Benchmark Analysis: Methodology 10.3. Benchmark Analysis: Peer Groups 11. LYOPHILIZATION CYCLE DEVELOPMENT AND OPTIMIZATION 11.1. Chapter Overview 11.2. Lyophilization Cycle Development 11.3. Lyophilization Cycle Optimization 11.4. Lyophilization Cycle Development and Optimization: Service Providers 11.5. Lyophilization Cycle Development and Optimization Service Providers: Company Snapshots 12. ALTERNATIVE APPROACHES TO LYOPHILIZATION 12.1. Chapter Overview 12.2. Spray Drying 12.3. Spray Freeze Drying 12.4. Atmospheric Spray Freeze Drying 12.5. Vacuum Foam Drying 13. SURVEY ANALYSIS 13.1. Chapter Overview 13.2. Seniority Level of Respondents 13.3. Type of Biopharmaceuticals Lyophilized 13.4. Type of Containment System 13.5. Scale of Operation 13.6. Lyophilization Cycle Development and Optimization 13.7. Location of Lyophilization Facility 13.8. Likely Market Size 14. CONCLUSION 14.1. In Light of High Costs Associated with Establishing In-house Lyophilization Capabilities, Outsourcing has Emerged as a Convenient Alternative 14.2. Cycle Development and Optimization are Among the Key Lyophilization Processes; a Number of Players Specializing in These Services Have Entered the Market Expanding the Value Chain 14.3. Although Alternative Methods have Gained Attention in Recent Times, Lyophilization will Continue to Play a Pivotal Role 14.4. Fueled by the Growing Pipeline of Biopharmaceuticals, the Market is Likely to Witness Continuous Growth in the Coming Decade 15. INTERVIEW TRANSCRIPTS 15.1. Chapter Overview 15.2. Steven Nail, Principal Scientist, Baxter BioPharma Solutions 15.3. Adam Viverette, Lyophilization Manager, Patheon 15.4. Patrick DePalma, Director, CMO Business Development BioDefense Division, Emergent BioSolutions 15.5. John Shaw, Head of Business Development and Marketing, Vibalogics Companies Mentioned - AB BioTechnologies - Affinity Biologicals - Affinity Life Sciences - Ajinomoto - Albany Molecular Research (AMRI) - Alcami - Althea - Amatsigroup - Anteco Pharma - Apexigen - Aptevo Therapeutics - AusiaBio - Avrio Biopharmaceuticals - Axcellerate Pharma - Axys-Network - BSP Pharmaceuticals - Baccinex - Baxter BioPharma Solutions - Bayer Healthcare - Berkshire Sterile Manufacturing (BSM) - BioConnection - BioReliance - BioTechLogic - BioTechnique - BioZed Engineering - Biocon - Biopharma Technology - Bioserv Corporation - Biotechpharma - Biovian - Boehringer Ingelheim BioXcellence - Bovogen Biologicals - Bryllan - Burrard Pharmaceuticals - CARBOGEN AMCIS - CEPiA - CMC Biologics - Camurus - Canada Peptide - Capua BioServices - Catalent - Cenexi - CinnaGen - Clarity BioSolutions - Cobra Biologics - Coldstream Laboratories - Cook Pharmica - Corden Pharma - Coriolis Pharma - CuriRx - Dalton Pharma Services - DavosPharma - EUCODIS Bioscience - Emergent BioSolutions - Engineered Biopharmaceuticals - Eurogentec - FUJIFILM Diosynth Biotechnologies - Famar Health Care Services - Fedegari Group - Formurex - Fresenius Kabi Product Partnering - Frontage Labs - GILYOS (GIeseler LYOphilization Solutions) - GP Pharm - Gipharma - GlaxoSmithKline (GSK) - Goodwin Biotechnology - Grand River Aseptic Manufacturing (GRAM) - HALIX - HTD Biosystems - Hart Biologicals - Hovione - Hycult Biotech - IDIFARMA - IDT Biologika - Infectious Disease Research Institute (IDRI) - Integrity Bio - Jubilant HollisterStier - Jubilant Pharma - KABS Pharmaceutical Services - KBI Biopharma - Kamat Pharmatech - Kemwell Biopharma - LEUKOCARE - LSNE Contract Manufacturing - LYOCONTRACT - Legacy BioDesign - Lonza - Lyofal - Lyophilization Technology - MabPlex - Markt Technologies - MassDevelopment - Medicago - Micro-sphere - Miltenyi Biotec - Mycenax Biotech - NanoTools - National Institute of Allergy and Infectious Diseases (NIAID) - Nitto Avecia Pharma Services - Nova Laboratories - OctoPlus - Oncotec Pharma Produktion - OsoBio - PREMAS Biotech - PYRAMID Laboratories - PaizaBio - Particle Sciences - Patheon - Pfizer CentreOne - Pharmagen - Pharmatek - Pierre Fabre - Piramal Pharma Solutions - Praxair - Praxis Pharmaceutical - ProJect Pharmaceutics - Quality BioResources - Recipharm - Rentschler - SGS Group - SP Scientific - SYNERLAB Group - Samsung Biologics - Sanofi - Siam Bioscience - Singota Solutions - StemProtein - Symbiosis Pharmaceutical Services - SynCo Bio Partners - Syngene - The Native Antigen Company (NAC) - Therapure Biomanufacturing - Tofflon - Universal Stabilization Technologies - Upperton - Vectura - Vetter Pharma - Vibalogics - VxP Pharma - Wolfe Laboratories - WuXi AppTec For more information about this report visit http://www.researchandmarkets.com/research/46rmjf/lyophilization